Shopping Cart 0
Cart Subtotal
USD 0

Hologic Inc (HOLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9

Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hologic Inc, Pharmaceuticals & Healthcare, Deal Details 11

Debt Offering 11

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 11

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 12

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 13

Acquisition 14

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 14

Hologic Inc-Key Competitors 16

Hologic Inc-Key Employees 17

Hologic Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Affiliate 21

Recent Developments 22

Financial Announcements 22

Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 22

May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 23

Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 25

Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately USD 791 Million in the First Quarter of Fiscal 2018 27

Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 28

Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 30

May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 32

Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 33

Corporate Communications 35

Jul 31, 2018: Hologic Announces Chief Financial Officer Change 35

Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 36

May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 37

Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 38

Legal and Regulatory 39

Aug 01, 2018: US judge finds Fujifilm infringed on Hologic's mammography patents 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Hologic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Hologic Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9

Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 11

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 12

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 13

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 14

Hologic Inc, Key Competitors 16

Hologic Inc, Key Employees 17

Hologic Inc, Other Locations 18

Hologic Inc, Subsidiaries 18

Hologic Inc, Affiliate 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Hologic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9

Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hologic Inc, Pharmaceuticals & Healthcare, Deal Details 11

Debt Offering 11

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 11

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 12

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 13

Acquisition 14

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 14

Hologic Inc-Key Competitors 16

Hologic Inc-Key Employees 17

Hologic Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Affiliate 21

Recent Developments 22

Financial Announcements 22

Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 22

May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 23

Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 25

Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately USD 791 Million in the First Quarter of Fiscal 2018 27

Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 28

Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 30

May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 32

Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 33

Corporate Communications 35

Jul 31, 2018: Hologic Announces Chief Financial Officer Change 35

Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 36

May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 37

Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 38

Legal and Regulatory 39

Aug 01, 2018: US judge finds Fujifilm infringed on Hologic's mammography patents 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Hologic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Hologic Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Hologic Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Hologic Inc, Medical Devices Deals, 2012 to YTD 2018 9

Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 11

Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 12

Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 13

Hologic Completes Acquisition Of Gen-Probe For USD 3.7 Billion 14

Hologic Inc, Key Competitors 16

Hologic Inc, Key Employees 17

Hologic Inc, Other Locations 18

Hologic Inc, Subsidiaries 18

Hologic Inc, Affiliate 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Hologic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.